[Skip to Content]
[Skip to Content Landing]
Views 1,682
Citations 0
Invited Commentary
June 2018

Building a Stronger Care Loop Through mHealth Technology

Author Affiliations
  • 1Division of Nephrology, Department of Medicine, Mount Sinai Hospital and University Health Network, Lunenfeld-Tanenbaum Research Institute, University of Toronto, Toronto, Ontario, Canada
JAMA Intern Med. 2018;178(6):809-811. doi:10.1001/jamainternmed.2018.1168

Achieving good blood pressure (BP) control and sustaining effective antihypertensive treatment remain a major challenge for those involved in the long-term management of hypertension. In the current issue, Morawski et al1 report the results of a study using a mobile health (mHealth) tool, called Medisafe, a highly rated smartphone app for medication management, which allows patients to track medication intake and home BP readings. In a relatively large, 3-month study, the authors demonstrated that patients with uncontrolled hypertension, randomized to using Medisafe, did not result in improved BP control compared with the control group. However, they did show a small, statistically significant, but clinically unimportant, improvement in medication adherence, measured by the 8-item Morisky Medication Adherence Scale. The study is a valuable addition to the growing body of literature assessing the role of mHealth technology in the health care sector; however, the results are disappointing for those of us who advocate for ongoing incorporation of mHealth strategies into current care.2

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Limit 140 characters
Limit 3600 characters or approximately 600 words